Pengbo Ning
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Enhanced CD33 CAR-NK cells secreting anti-CD73scFv overcome adenosine-mediated immunosuppression and improve anti-AML efficacy.
Journal: Journal for immunotherapy of cancer
Published: August 16, 2026
Engineering TME-activated CD47-specific CAR macrophage via Arg1 promoter for safe and effective solid tumor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 23, 2025
Breaking the immunosuppressive barrier: an armored CAR-M biotechnology with the original M1 phenotype dominance rescues antitumor immunity.
Journal: Trends in biotechnology
Published: April 29, 2025
Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy.
Journal: Materials today. Bio
Published: December 30, 2024
An epigenetic regulator synergizes with alphavirus-mediated gene therapy via biomimetic delivery for enhanced cancer therapy.
Journal: Trends in biotechnology
Published: August 11, 2024
An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 24, 2024
Ingenious designed a HER2-Specific macrophage biomimetic multifunctional nanoplatform for enhanced bio-photothermal synergistic therapy in HER2 positive breast cancer.
Journal: Materials today. Bio
Published: February 01, 2024
Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 10, 2023
NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death.
Journal: Biomaterials science
Published: June 19, 2023
Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
Journal: Journal of nanobiotechnology
Published: May 04, 2023
Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy.
Journal: Molecular pharmaceutics
Published: March 29, 2023
Last Updated: 09/26/2026